Skip to main content
NCBI home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2008 Oct 9;10(4):884–895. doi: 10.1111/j.1582-4934.2006.tb00532.x

Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression

Peter Brock a, Gisela Sparmann a, Thomas Ritter b, Robert Jaster a,*, Stefan Liebe a, Jörg Emmrich a
PMCID: PMC3933084  PMID: 17125592

Abstract

Pancreatic stellate cells (PSC) are crucially involved in the development of fibrosis, a hallmark of chronic pancreatitis. Therefore, PSC represent an attractive target for the modulation of cellular functions providing the prerequisite for the establishment of novel therapeutic strategies like transfer of genetic material to the cells. Based on recent studies suggesting that the chronic course of pancreatitis is associated with immune deviation towards a Th1 cytokine profile, we have investigated the applicability of primary PSC to an adenovirus-mediated transfer of the cDNA encoding the Th2 cytokine interleukin (IL) 4 and the autocrine-acting effects of IL 4 on the cells in vitro. The trans-duction of primary PSC with a replication-incompetent adenovirus type 5 vector carrying the cDNA encoding rat IL-4 resulted in a distinct expression of the cytokine on mRNA and protein level for two weeks. Similar to recombinant IL 4, effects of the endogenously synthesized cytokine were mediated by the signal transducer and activator of transcription (STAT)6. Interestingly, beside the increase of PSC proliferation, IL 4 transduction was accompanied by an up-regulation in the endogenous expression of the anti-inflammatory cytokine IL 10. In summary, our data suggest that PSC are suitable targets for gene therapy modulating cellular interactions in the pancreas.

Keywords: adenoviral gene transfer, interleukin 4, interleukin 10, pancreatic stellate cells

References

  • 1.Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash S, Logsdon CD, Simeone DM. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas. 2004;29:254–63. doi: 10.1097/00006676-200411000-00003. [DOI] [PubMed] [Google Scholar]
  • 2.Kloppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas. 1993;8:659–70. doi: 10.1097/00006676-199311000-00001. [DOI] [PubMed] [Google Scholar]
  • 3.Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534–41. doi: 10.1136/gut.44.4.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer. 2004;3:26. doi: 10.1186/1476-4598-3-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kruse ML, Hildebrand PB, Timke C, Folsch UR, Schmidt WE. TGFbeta1 autocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro. Regul Pept. 2000;90:47–52. doi: 10.1016/s0167-0115(00)00104-x. [DOI] [PubMed] [Google Scholar]
  • 6.Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–33. doi: 10.1136/gut.43.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sparmann G, Hohenadl C, Tornoe J, Jaster R, Fitzner B, Koczan D, Thiesen HJ, Glass A, Winder D, Liebe S, Emmrich J. Generation and characterization of immortalized rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004;287:G211–9. doi: 10.1152/ajpgi.00347.2003. [DOI] [PubMed] [Google Scholar]
  • 8.Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J. The promise of gene therapy in gastrointestinal and liver diseases. Gut. 2003;52:ii49–54. doi: 10.1136/gut.52.suppl_2.ii49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Russell WC. Update on adenovirus and its vectors. J Gen Virol. 2000;81:2573–604. doi: 10.1099/0022-1317-81-11-2573. [DOI] [PubMed] [Google Scholar]
  • 10.Ebert MP, Ademmer K, Muller-Ostermeyer F, Friess H, Buchler MW, Schubert W, Malfertheiner P. CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am J Gastroenterol. 1998;93:2141–7. doi: 10.1111/j.1572-0241.1998.00610.x. [DOI] [PubMed] [Google Scholar]
  • 11.Emmrich J, Weber I, Nausch M, Sparmann G, Koch K, Seyfarth M, Lohr M, Liebe S. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion. 1998;59:192–8. doi: 10.1159/000007488. [DOI] [PubMed] [Google Scholar]
  • 12.Hunger RE, Mueller C, Z’graggen K, Friess H, Buchler MW. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology. 1997;112:1656–63. doi: 10.1016/s0016-5085(97)70048-9. [DOI] [PubMed] [Google Scholar]
  • 13.Sparmann G, Behrend S, Merkord J, Kleine HD, Graser E, Ritter T, Liebe S, Emmrich J. Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride. Dig Dis Sci. 2001;46:1647–56. doi: 10.1023/a:1010689117772. [DOI] [PubMed] [Google Scholar]
  • 14.Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol. 1997;15:297–322. doi: 10.1146/annurev.immunol.15.1.297. [DOI] [PubMed] [Google Scholar]
  • 15.Cameron MJ, Arreaza GA, Waldhauser L, Gauldie J, Delovitch TL. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. Gene Ther. 2000;7:1840–6. doi: 10.1038/sj.gt.3301309. [DOI] [PubMed] [Google Scholar]
  • 16.Prud’homme GJ. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J Gene Med. 2000;2:222–32. doi: 10.1002/1521-2254(200007/08)2:4<222::AID-JGM117>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 17.Van de Loo FA, van den Berg WB. Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. Rheum Dis Clin North Am. 2002;28:127–49. doi: 10.1016/s0889-857x(03)00073-5. [DOI] [PubMed] [Google Scholar]
  • 18.Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA. 1994;91:215–9. doi: 10.1073/pnas.91.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ritter T, Vogt K, Rieck P, Schilling-Schon A, Kolls J, Hartmann C, Volk HD, Pleyer U. Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res. 1999;69:563–8. doi: 10.1006/exer.1999.0731. [DOI] [PubMed] [Google Scholar]
  • 20.Sparmann G, Glass A, Brock P, Jaster R, Koczan D, Thiesen HJ, Liebe S, Emmrich J. Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15. Am J Physiol Gastrointest Liver Physiol. 2005;289:G842–51. doi: 10.1152/ajpgi.00483.2004. [DOI] [PubMed] [Google Scholar]
  • 21.Brock P, Sparmann G, Ritter T, Jaster R, Liebe S, Emmrich J. Interleukin-4 gene transfer into rat pancreas by recombinant adenovirus. Scand J Gastroenterol. 2005;40:1109–17. doi: 10.1080/00365520510023404. [DOI] [PubMed] [Google Scholar]
  • 22.Jaster R, Lichte P, Fitzner B, Brock P, Glass A, Karopka T, Gierl L, Koczan D, Thiesen HJ, Sparmann G, Emmrich J, Liebe S. Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J Cell Mol Med. 2005;9:670–82. doi: 10.1111/j.1582-4934.2005.tb00497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chomarat P, Banchereau J. An update on interleukin-4 and its receptor. Eur Cytokine Netw. 1997;8:333–44. [PubMed] [Google Scholar]
  • 24.Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33–40. doi: 10.1038/83324. [DOI] [PubMed] [Google Scholar]
  • 25.Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature. 1997;389:239–42. doi: 10.1038/38410. [DOI] [PubMed] [Google Scholar]
  • 26.Fontana L, Nuzzo M, Urbanelli L, Monaci P. General strategy for broadening adenovirus tropism. J Virol. 2003;77:11094–104. doi: 10.1128/JVI.77.20.11094-11104.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hidaka C, Milano E, Leopold PL, Bergelson JM, Hackett NR, Finberg RW, Wickham TJ, Kovesdi I, Roelvink P, Crystal RG. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest. 1999;103:579–87. doi: 10.1172/JCI5309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wersto RP, Rosenthal ER, Crystal RG, Spring KR. Uptake of fluorescent dyes associated with the functional expression of the cystic fibrosis transmembrane conductance regulator in epithelial cells. Proc Natl Acad Sci USA. 1996;93:1167–72. doi: 10.1073/pnas.93.3.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol. 2005;174:6440–8. doi: 10.4049/jimmunol.174.10.6440. [DOI] [PubMed] [Google Scholar]
  • 30.de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995;27:537–41. doi: 10.3109/07853899509002465. [DOI] [PubMed] [Google Scholar]
  • 31.Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 1992;148:3133–9. [PubMed] [Google Scholar]
  • 32.Morita Y, Yamamura M, Kawashima M, Aita T, Harada S, Okamoto H, Inoue H, Makino H. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflamma-tory cytokine production and fibroblast proliferation in rheumatoid synovium. Rheumatol Int. 2001;20:49–54. doi: 10.1007/s002960000074. [DOI] [PubMed] [Google Scholar]
  • 33.Furukawa H, Oshima K, Tung T, Cui G, Laks H, Sen L. Liposome-mediated combinatorial cytokine gene therapy induces localized synergistic immunosuppression and promotes long-term survival of cardiac allografts. J Immunol. 2005;174:6983–92. doi: 10.4049/jimmunol.174.11.6983. [DOI] [PubMed] [Google Scholar]
  • 34.Rogy MA, Beinhauer BG, Reinisch W, Huang L, Pokieser P. Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum. Hum Gene Ther. 2000;11:1731–41. doi: 10.1089/10430340050111386. [DOI] [PubMed] [Google Scholar]
  • 35.Kuroda K, Shinkai H. Downregulation of decorin expression in dermal fibroblasts by interleukin-4. Arch Dermatol Res. 1997;289:476–80. doi: 10.1007/s004030050224. [DOI] [PubMed] [Google Scholar]
  • 36.Paul WE. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found Symp. 1997;204:208–16. doi: 10.1002/9780470515280.ch14. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES